Physician

David H Snow, M.D.

According to 2025 Medicare claims, David Snow, M.D. (NPI: 1639177082) practices rheumatology in the Wilmington, NC market, with the plurality of this provider's patient population coming from Brunswick, NC. This provider's primary affiliated billing organization is CAPE FEAR ARTHRITIS CARE, PLLC (NPI: 1851718142; TIN: 464922021) and primary practice location at 28451-4168. Snow is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Snow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 696 traditional Medicare patients, billed 419,241 HCPCS/CPT codes, and received $4,234,186 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,709 prescription claims across 414 beneficiaries totaling $883,062 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2016 DME data shows 12 claims. Open Payments data shows 164 records totaling $336,634. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $768,398 to $4,234,186. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	526	32,729	$768,398
2016	575	55,196	$1,365,538
2017	679	57,270	$1,486,588
2018	685	94,544	$2,092,505
2019	751	213,874	$3,117,400
2020	679	312,705	$4,675,033
2021	759	310,694	$4,859,579
2022	749	319,632	$5,516,306
2023	677	356,965	$4,136,148
2024	696	419,241	$4,234,186

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	399	4,755	$842,479
2016	411	2,745	$969,065
2017	431	3,004	$1,464,743
2018	460	2,829	$1,813,270
2019	452	2,839	$1,906,781
2020	477	2,500	$1,674,643
2021	488	2,381	$2,153,839
2022	450	2,007	$1,226,671
2023	414	1,881	$1,118,427
2024	414	1,709	$883,062

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	43	$1,633
2016	N/R	12	$734
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	180	1,186	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	379	502	$87
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	214	1,301	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	262	324	$12
36415	Insertion of needle into vein for collection of blood sample	314	432	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	25	700	$165,795
Enbrel Sureclick	Etanercept	17	476	$144,536
Cosentyx Sensoready (2 Pens)	Secukinumab	15	420	$108,152
Rinvoq	Upadacitinib	14	420	$83,102
Xeljanz Xr	Tofacitinib Citrate	14	420	$78,028

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	129	$3,119	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	35	$333,515	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David H. Snow, M.D.?

Tedicare shows public-source Medicare data for David H. Snow, M.D. (NPI 1639177082), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David H. Snow, M.D. have ACO affiliation data?

David H. Snow, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to David H. Snow, M.D.?

David H. Snow, M.D. is linked to CAPE FEAR ARTHRITIS CARE, PLLC (billing NPI 1851718142) in the available physician profile data.

Does David H. Snow, M.D. have Open Payments data?

David H. Snow, M.D. has 164 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.